Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hainaud, P.
Right arrow Articles by Dupuy, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hainaud, P.
Right arrow Articles by Dupuy, E.
[Cancer Research 66, 8501-8510, September 1, 2006]
© 2006 American Association for Cancer Research


Cell, Tumor, and Stem Cell Biology

The Role of the Vascular Endothelial Growth Factor–Delta-like 4 Ligand/Notch4-Ephrin B2 Cascade in Tumor Vessel Remodeling and Endothelial Cell Functions

Patricia Hainaud, Jean-Olivier Contrerès, Aude Villemain, Lang-Xia Liu, Jean Plouët, Gérard Tobelem and Evelyne Dupuy

Institut des Vaisseaux et du Sang, INSERM U689, IFR139, Paris VII-Denis Diderot, Hôpital Lariboisière, Paris, France

Requests for reprints: Evelyne Dupuy, Institut des Vaisseaux et du Sang, INSERM U689, IFR139, Paris VII-Denis Diderot, Hôpital Lariboisière, 8 rue Guy Patin, 75475 Paris, Cedex 10, France. Phone: 33-1-45-26-21-98; Fax: 33-1-42-82-94-73; E-mail: evelyne.dupuy{at}lrb.aphp.fr.

Vascular endothelial growth factor (VEGF) and Delta-like 4 ligand (DLL4) are the only genes whose haploinsufficiency results in vascular abnormalities. Although many common pathways are up-regulated in both vascular development and tumor angiogenesis and in vascular remodeling, the role of the Delta/Notch pathway has not been clearly defined in tumor angiogenesis. In this study, we assessed the expression of DLL4, Notch4, and ephrin B2 in transgenic mice developing hepatocarcinoma characterized by a strong remodeling of the tumor sinusoids. We also investigated the role of VEGF in the expression and biological functions of these molecules on human venous endothelial cells. In transgenic livers, we showed that DLL4, active Notch4, and ephrin B2 were gradually up-regulated within the hepatocarcinoma progression and expressed on tumor sinusoidal endothelial cells. In venous endothelial cells, we showed that VEGF up-regulates DLL4 and presenilin, and increased the activation of Notch4, leading to an up-regulation of ephrin B2 with a down-regulation of Eph B4. We also showed that the activation of Notch4 is required for VEGF-induced up-regulation of ephrin B2 and the differentiation of human venous endothelial cells in vitro. Accordingly, the disruption of Notch4 signaling by pharmacologic inhibition of presenilin or addition of soluble DLL4 inhibited the effect of VEGF on human venous endothelial cell migration and differentiation. Our study strongly suggests that a coordinated activation of DDL4/Notch4 and ephrin B2 pathways downstream of VEGF plays a key role in the abnormal remodeling of tumor vessels. (Cancer Res 2006; 66(17): 8501-10)




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
D. Morrow, J. P. Cullen, P. A. Cahill, and E. M. Redmond
Ethanol stimulates endothelial cell angiogenic activity via a Notch- and angiopoietin-1-dependent pathway
Cardiovasc Res, July 15, 2008; 79(2): 313 - 321.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Funahashi, S. L. Hernandez, I. Das, A. Ahn, J. Huang, M. Vorontchikhina, A. Sharma, E. Kanamaru, V. Borisenko, D. M. DeSilva, et al.
A Notch1 Ectodomain Construct Inhibits Endothelial Notch Signaling, Tumor Growth, and Angiogenesis
Cancer Res., June 15, 2008; 68(12): 4727 - 4735.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. M.S. van den Akker, V. Caolo, L. J. Wisse, P. P.W.M. Peters, R. E. Poelmann, P. Carmeliet, D. G.M. Molin, and A. C. Gittenberger-de Groot
Developmental coronary maturation is disturbed by aberrant cardiac vascular endothelial growth factor expression and Notch signalling
Cardiovasc Res, May 1, 2008; 78(2): 366 - 375.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Mazella, S. Liang, and L. Tseng
Expression of Delta-Like Protein 4 in the Human Endometrium
Endocrinology, January 1, 2008; 149(1): 15 - 19.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
C. Roca and R. H. Adams
Regulation of vascular morphogenesis by Notch signaling
Genes & Dev., October 15, 2007; 21(20): 2511 - 2524.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Konishi, K. S. Kawaguchi, H. Vo, N. Haruki, A. Gonzalez, D. P. Carbone, and T. P. Dang
{gamma}-Secretase Inhibitor Prevents Notch3 Activation and Reduces Proliferation in Human Lung Cancers
Cancer Res., September 1, 2007; 67(17): 8051 - 8057.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
T. Gridley
Notch signaling in vascular development and physiology
Development, August 1, 2007; 134(15): 2709 - 2718.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. A. Kudo, A. Muto, S. P. Maloney, J. M. Pimiento, S. Bergaya, T. N. Fitzgerald, T. S. Westvik, J. C. Frattini, C. K. Breuer, C. H. Cha, et al.
Venous Identity Is Lost but Arterial Identity Is Not Gained During Vein Graft Adaptation
Arterioscler. Thromb. Vasc. Biol., July 1, 2007; 27(7): 1562 - 1571.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. S. Scehnet, W. Jiang, S. Ram Kumar, V. Krasnoperov, A. Trindade, R. Benedito, D. Djokovic, C. Borges, E. J. Ley, A. Duarte, et al.
Inhibition of Dll4-mediated signaling induces proliferation of immature vessels and results in poor tissue perfusion
Blood, June 1, 2007; 109(11): 4753 - 4760.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. Takeshita, M. Satoh, M. Ii, M. Silver, F. P. Limbourg, Y. Mukai, Y. Rikitake, F. Radtke, T. Gridley, D. W. Losordo, et al.
Critical Role of Endothelial Notch1 Signaling in Postnatal Angiogenesis
Circ. Res., January 5, 2007; 100(1): 70 - 78.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.